Partner Therapeutics, Inc. (PTx), a private, fully-integrated biotechnology company announced today that the New England Journal of Medicine (NEJM) published results of the 204-patient, global, ...
1h
UTRECHT, The Netherlands and CAMBRIDGE, Mass., Feb. 05, 2025 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq: MRUS) (Merus, the Company, we, or our), a ...
The U.S. Food and Drug Administration has approved a new non-opioid pain medication developed by Boston-based Vertex ...
After combing through 4,000 existing medications, an artificial intelligence tool helped uncover one that saved the life of a ...
A 41-year-old man was evaluated for swelling in the ankles and syncope. CT of the chest showed bilateral mediastinal and ...
The blood pressure study could help doctors treating people with diabetes to reduce the risk of "major cardiovascular events" ...
Patients with a common heart rhythm disorder who took an experimental blood-thinning drug had far fewer bleeding episodes ...
Drug experts Drs. Volkow and McLellan set out a road map to reverse the opioid epidemic in 2016. Find out how we're doing now ...
Tuberculosis remains one of the top infectious disease killers worldwide, a challenge amplified by drug-resistant forms of ...
UTRECHT, The Netherlands and CAMBRIDGE, Mass., Feb. 05, 2025(Nasdaq: MRUS) (Merus, the Company, we, or our), a clinical-stage oncology company developing innovative, full-length multispecific antibodi ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback